Search Icon
CRDF Archived Articles

Cardiff Oncology (CRDF): Pioneering Innovative Cancer Therapies

Published on March 13, 2025

Cardiff Oncology, Inc. (NASDAQ:CRDF): Promising Data Supports Onvansertib's Potential in First-Line RAS-Mutated Metastatic Colorectal Cancer

Published on September 24, 2024